Brief: WPD Pharmaceuticals Partners With CNS Pharmaceuticals On Drug Development For Coronavirus And Other Antiviral Indications
March 24 (Reuters) - WPD Pharmaceuticals Inc WBIO.CD :
* WPD PHARMACEUTICALS PARTNERS WITH CNS PHARMACEUTICALS ON
DRUG
DEVELOPMENT FOR CORONAVIRUS AND OTHER ANTIVIRAL INDICATIONS
Source text for Eikon: ID:nGNX78l50M
Further company coverage: WBIO.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNS Pharmaceuticals
See all newsCNS Pharmaceuticals Q2 net loss widens, cash rises after financing
CNS Pharmaceuticals Inc expected to post a loss of 24 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:44 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:32 AM
Brief: Cns Pharmaceuticals Appoints Rami Levin As CEO Effective Jan 1, 2026